MHRA-102001-PIP01-25

Key Facts

Active Substance
Active Substance:
  • FEZOLINETANT
Invented Name
  • Veoza
  • Veoza
  • VEOZA
  • Veozah
  • Veoza
  • Veozah
  • Veoza
  • Veoza
  • Veoza 45 mg
  • Veoza
  • Veozah
  • Veoza
  • Veoza
  • Veozah
  • Veoza
PIP Number MHRA-102001-PIP01-25
Pharmaceutical form(s)
Pharmaceutical form(s):
  • All pharmaceutical forms.
Therapeutic area
Therapeutic area:
  • Other: Women's Health
Conditions / Indications
Conditions / Indications:
  • Treatment of vasomotor symptoms caused by endocrine therapy related to breast cancer
Route(s) of administration
Route(s) of administration:
  • All routes of administration.
PIP applicant
Decision Type
Decision Type
W: decision granting a waiver in all age groups for the listed condition(s).
Compliance Check
Compliance Check
No
Compliance Check Decision Date
Compliance Check Procedure Number

Decision Document

Decision Document Decision Document on a Paediatric Investigation Plan (PIP):FEZOLINETANT.pdf
Published Date 16/01/2026